Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Reversal of Anticoagulation : Protamine

Lindblad, Bengt LU and Holst, Jan LU (2009) p.287-293
Please use this url to cite or link to this publication:
author
and
organization
publishing date
type
Chapter in Book/Report/Conference proceeding
publication status
published
subject
keywords
Haemodynamic adverse response to protamine reversal of anticoagulation, Low-molecular-weight heparins (LMWH) as anticoagulant agents, Mechanism of action-reversal of heparinization, Monitoring neutralizing effect of protamine, New pharmacological agents-direct thrombin inhibitors and factor Xa inhibitors, Nonimmunological reactions-cell-membrane interactions and cascade systems interactions, Reversal of anticoagulation-protamine, Tissue factor pathway inhibitor (TFPI), Type I and III immunological reactions and Coombs and Gell's classification, Unfractionated heparin (UH)-substance of choice minimizing risk of thrombotic complications
host publication
Pharmacology in the Catheterization Laboratory
editor
Waksman, Ron and Ajani, Andrew E.
pages
287 - 293
publisher
Wiley-Blackwell
external identifiers
  • scopus:84889397699
ISBN
9781405157049
9781444306347
DOI
10.1002/9781444306347.ch38
language
English
LU publication?
yes
id
8bf54c63-a56b-4d73-a08e-55cb456981a6
date added to LUP
2018-03-23 12:48:30
date last changed
2025-01-08 07:14:08
@inbook{8bf54c63-a56b-4d73-a08e-55cb456981a6,
  author       = {{Lindblad, Bengt and Holst, Jan}},
  booktitle    = {{Pharmacology in the Catheterization Laboratory}},
  editor       = {{Waksman, Ron and Ajani, Andrew E.}},
  isbn         = {{9781405157049}},
  keywords     = {{Haemodynamic adverse response to protamine reversal of anticoagulation; Low-molecular-weight heparins (LMWH) as anticoagulant agents; Mechanism of action-reversal of heparinization; Monitoring neutralizing effect of protamine; New pharmacological agents-direct thrombin inhibitors and factor Xa inhibitors; Nonimmunological reactions-cell-membrane interactions and cascade systems interactions; Reversal of anticoagulation-protamine; Tissue factor pathway inhibitor (TFPI); Type I and III immunological reactions and Coombs and Gell's classification; Unfractionated heparin (UH)-substance of choice minimizing risk of thrombotic complications}},
  language     = {{eng}},
  month        = {{10}},
  pages        = {{287--293}},
  publisher    = {{Wiley-Blackwell}},
  title        = {{Reversal of Anticoagulation : Protamine}},
  url          = {{http://dx.doi.org/10.1002/9781444306347.ch38}},
  doi          = {{10.1002/9781444306347.ch38}},
  year         = {{2009}},
}